Skip to main content

Constipation clinical trials at UC Health
2 research studies open to eligible people

  • Naloxegol in Cancer Opioid-Induced Constipation

    open to eligible people ages 18 years and up

    The purpose of this study is to compare the effect of naloxegol versus the patient's usual care in treating opioid-induced constipation, as well as the effect on the patient's quality of life and how much pain is experienced. Also, the purpose of this study is to compare whether treatment with naloxegol versus usual care has any impact on the number of hospital or clinic visits or telephone calls to the patient's physician that are related to constipation, and to determine the patient's preference for continuing to receive naloxegol as treatment for opioid-induced constipation.

    at UCSD

  • S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

    open to eligible people ages 18 years and up

    This phase II trial studies how well isatuximab works in treating patients with primary amyloidosis that has come back or does not respond to treatment. Monoclonal antibodies, such as isatuximab, may interfere with the ability of cancer cells to grow and spread.

    at UC Davis UC Irvine

Last updated: